Current pharmacologic treatment of multiple sclerosis symptoms

About 350,000 persons in the United States have multiple sclerosis, and primary care physicians are often called on to provide symptomatic therapy for these patients. We review our current pharmacologic approach to the management of multiple sclerosis exacerbations and the symptoms of spasticity, fa...

Full description

Saved in:
Bibliographic Details
Published in:The Western journal of medicine 1996-11, Vol.165 (5), p.313-317
Main Authors: Andersson, P B, Goodkin, D E
Format: Article
Language:English
Subjects:
Defecation
Depressive Disorder - drug therapy
Depressive Disorder - etiology
Drug therapy
Fatigue - drug therapy
Fatigue - etiology
Humans
Multiple sclerosis
Multiple Sclerosis - complications
Multiple Sclerosis - drug therapy
Muscle Spasticity - drug therapy
Muscle Spasticity - etiology
Pain - drug therapy
Pain - etiology
Urination Disorders - drug therapy
Urination Disorders - etiology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:About 350,000 persons in the United States have multiple sclerosis, and primary care physicians are often called on to provide symptomatic therapy for these patients. We review our current pharmacologic approach to the management of multiple sclerosis exacerbations and the symptoms of spasticity, fatigue, bladder and bowel involvement, neurobehavioral complaints, pain syndromes, dystonic spasms, and tremor and ataxia.
ISSN:0093-0415
1476-2978